Elisa Salvati

Elisa Salvati

Auto-generated profile, based on publicly available information

Elisa Salvati

IFOM, The FIRC Institute for Molecular Oncology Foundation, IFOM-IEO Campus, 20139 Milan, Italy

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2018 in Chemical Communications
Verified
Journal Article
Open access
PDF file
LGLuis Antonio Serrano González
Luis Antonio Serrano González
YYYe Yang
Ye Yang
ESElisa Salvati
Elisa Salvati
FSFrancesco Stellacci
Francesco Stellacci
SKSilke Krol
Silke Krol
SGStefan Guldin
Stefan Guldin
At present, drug dosage is based on standardised approaches that disregard pharmakokinetic differences between patients and lead to non-optimal efficacy and unnecessary side effects. In this work, we demonstrate the potential of pH-mediated fluorescence spectroscopy for therapeutic drug monitoring in complex media. We apply this principle to the simultaneous quantification of the chemotherapeutic prodrug Irinotecan and its active metabolite SN-38 from human plasma across the clinically relevant concentration range, i.e. from micromolar to nanomolar at molar ratios of up to 30 : 1.